Direct and indirect costs associated to type 2 diabetes and its complications measured in a social security institution of Argentina

International Journal of Public Health

Volumn 59, Issue 5, 2014, Pages 851-857

  Elgart, Jorge F ^a   Asteazarán, Santiago ^a   De La Fuente, Jorge L ^b   Camillucci, Cecilia ^b   Brown, Jonathan B ^c   Gagliardino, Juan José ^a  

^a University of La Plata CONICET   (Argentina)

^b HOSPITAL PRIVADO   (Argentina)

^c Northeast Health Resource Center   (United States)

Author keywords

Argentina; Chronic complications; Direct costs; Indirect costs; Type 2 diabetes

Indexed keywords

ADULT; AGE; AGED; ARGENTINA; CASE CONTROL STUDY; COMPARATIVE STUDY; COST OF ILLNESS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; ECONOMICS; FEMALE; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; SEX DIFFERENCE; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ARGENTINA; CASE-CONTROL STUDIES; COST OF ILLNESS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 84919599158     PISSN: 16618556     EISSN: 1420911X     Source Type: Journal    
DOI: 10.1007/s00038-014-0604-4     Document Type: Article

References (28)

1. Alexander GC, Sehgal NL, Moloney RM, Stafford RS (2008) National trends in treatment of type 2 diabetes mellitus, 1994–2007. Arch Intern Med 168(19):2088–2094
2. Alhowaish AK (2013) Economic costs of diabetes in Saudi Arabia. J Family Community Med 20(1):1–7
3. American Diabetes Association (2013a) Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36(4):1033–1046
4. American Diabetes Association (2013b) Standards of medical care in diabetes. Diabetes Care 36(Suppl1):S11–S66
5. Arredondo A, Reyes G (2013) Health disparities from economic burden of diabetes in middle-income countries: evidence from México. PLoS One 8(7):e68443. doi:10.1371/journal.pone.0068443
6. Bahia LR, Araujo DV, Schaan BD et al (2011) The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system. Value Health 14(Suppl 1):S137–S140. doi:10.1016/j.jval.2011.05.009
7. Bertoldi AD, Kanavos P, França GV et al (2013) Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review. Global Health 9:62. doi:10.1186/1744-8603-9-62
8. Caporale JE, Elgart JF, Gagliardino JJ (2013) Diabetes in Argentina: cost and management of diabetes and its complications and challenges for health policy. Global Health 9:54. doi:10.1186/1744-8603-9-54
9. Elgart JF, Caporale JE, Asteazaran S et al (2014) Association between socioeconomic status, type 2 diabetes and its chronic complications in Argentina. Diabetes Res Clin Pract 104(2):241–247
10. Ferrante D, Linetzky B, Konfino J et al (2011) Encuesta Nacional de Factores de Riesgo 2009: evolución de la epidemia de enfermedades crónicas no transmisibles en Argentina. Estudio de corte transversal. Rev Argent Salud Pública 2:34–41
11. Gagliardino JJ, Etchegoyen G et al (2001) A model educational program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNID-LA). Diabetes Care 24(6):1001–1007
12. Gagliardino JJ, Olivera E, Etchegoyen GS et al (2006) PROPAT: a study to improve the quality and reduce the cost of diabetes care. Diabetes Res Clin Pract 72(3):284–291
13. Gagliardino JJ, Aschner P, Baik SH et al (2012) Patients’ education and its impact on care outcomes, resource consumption and working conditions: data from the International Diabetes Management Practices Study (IDMPS). Diabetes Metab 38(2):128–134
14. Gagliardino JJ, Lapertosa S, Pfirter G et al (2013) Clinical, metabolic and psychological outcomes and treatment costs of a prospective randomized trial based on different educational strategies to improve diabetes care (PRODIACOR). Diabet Med 30(9):1102–1111
15. Hex N, Bartlett C, Wright D, Taylor M, Varley D (2012) Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med 29(7):855–862
16. International Diabetes Federation (2010) Diabetes Social and Economic Impact Studies. http://www.idf.org/diabetes-social-and-economic-impact-studies/
17. International Diabetes Federation (2011) IDF Diabetes Atlas, Fifth Edition. Brussels: International Diabetes Federation. www.diabetesatlas.org
18. Jönsson B, CODE-2 Advisory Board (2002) Revealing the cost of Type II diabetes in Europe. Diabetologia 45(7):S5–S12
19. Le C, Lin L, Jun D et al (2013) The economic burden of type 2 diabetes mellitus in rural southwest China. Int J Cardiol 165(2):273–277
20. Leśniowska J, Schubert A, Wojna M, Skrzekowska-Baran I, Fedyna M (2014) Costs of diabetes and its complications in Poland. Eur J Health Econ 15(6):653–660
21. Rice DP (1967) Estimating the cost of illness. Am J Public Health Nations Health 13(3):424–440
22. Trento M, Gamba S, Gentile L et al (2010) Rethink organization to iMprove education and outcomes (ROMEO): a multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes. Diabetes Care 33(4):745–747
23. Tunceli K, Bradley CJ, Nerenz D, Williams LK, Pladevall M, Elston Lafata J (2005) The impact of diabetes on employment and work productivity. Diabetes Care 28(11):2662–2667
24. Williams R, Van Gaal L, Lucioni C, CODE-2 Advisory Board (2002) Assessing the impact of complications on the costs of Type II diabetes. Diabetologia 45(7):S13–S17
25. World Health Organization (2008) International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) version: 2008. http://www.who.int/classifications/icd/en/
26. Yang W, Zhao W, Xiao J et al (2012) Medical care and payment for diabetes in China: enormous threat and great opportunity. PLoS One 7(9):e39513. doi:10.1371/journal.pone.0039513
27. Zhang P, Zhang X, Brown J et al (2010) Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 87(3):293–301
28. Zhuo X, Zhang P, Hoerger TJ (2013) Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. Am J Prev Med 45(3):253–261